Skip to main content
. Author manuscript; available in PMC: 2014 May 21.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Aug 31;4(10):1580–1589. doi: 10.1158/1940-6207.CAPR-11-0036

Table 1.

Patient characteristics

Variable Frequency
Percent P-value
Celecox Plbo Total
Gender Female 12 12 24 16.44 0.82
Male 64 58 122 83.56
Total 76 70 146 100
Race Caucasian 69 63 132 90.41 0.87
Asian 1 1 2 1.37
Black 3 0 3 2.05
Hispanic/Latin American 3 4 7 4.79
Native American 0 2 2 1.37
Total 76 70 146 100
Weekly doses of BCG 1 8 2 10 6.85 0.10
2 3 6 9 6.16
3 64 58 122 83.56
Other 1 4 5 3.42
Total 76 70 146 100.00
Previous NSAID use No 65 63 128 87.67 0.41
Yes 11 7 18 12.33
Total 76 70 146 100.00
Take Aspirin? (≤100mg/day) No 50 45 95 65.07 0.85
Yes 26 25 51 34.93
Total 76 70 146 100.00
Hypertension Missing 0 1 1 0.68 0.01
1: No 41 23 64 43.84
2: Yes, history 1 4 5 3.42
3: Yes, current 34 42 76 52.05
Total 76 70 146 100.00
Alcoholic drinks per day 1: None 29 28 57 39.04 0.42
2: <=1 26 23 49 33.56
3: 2-3 5 6 11 7.53
4: >=4 16 13 29 19.86
Total 76 70 146 100.00
Smoking status 1: Never 16 17 33 22.60 0.07
2: Former 41 46 87 59.59
3: Current 19 7 26 17.81
Total 76 70 146 100.00
Zubrod/ECOG Performance Status 0: Fully active 72 65 137 93.84 0.64
1: Restricted but ambulatory 4 5 9 6.16
Total 76 70 146 100
Stage TA 42 36 78 53.42 0.41
T1 17 20 37 25.34
T1+TA 2 1 3 2.05
T1+TIS 0 3 3 2.05
TIS 11 8 19 13.01
TA+TIS 4 2 6 4.11
Total 76 70 146 100